Commonly Used in Research
Please forward all questions and comments regarding the following information to Radiation Safety at 6-7055.
Commonly Used in Research
Please forward all questions and comments regarding the following information to Radiation Safety at 6-7055.
(CA-45)
Physical Data:
Pure Beta Emitter | |
---|---|
|
258 keV (max.) 77.2 keV (avg.) |
|
162.61 days 162 days 1.8 x 104 days 47.91 cm |
Radiological Data:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
2000 µCi: (by ingestion) 8000 µCi: (by inhalation) |
|
4 x 10 -7 µCi/mL |
Special Considerations:
In general, Calcium-45 does not require any special precautions over and above those necessary for any beta-emitting radionuclide of this energy of emissions. The majority of Calcium-45 is deposited in the bone and is retained with a long biological half-life.
Physical Data:
Pure Beta Emitter | |
---|---|
|
156.5 keV (max.) 49.47 keV (avg.) |
|
5730 years 12 days 40 days (unbound) 12 days (bound) 21.9 cm 0.28 mm 0.25 mm |
Radiological Data:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
2400 µCi: (by ingestion) 2000 µCi: (by inhalation) |
|
1 x 10 -6 µCi/mL |
Special Considerations:
There is a possibility that some organic compounds can be absorbed through gloves. Care needs to be taken not to generate carbon dioxide, which could be inhaled. Urinalysis is recommended after a spill or suspected intake.
Physical Data:
Intensity | ||
---|---|---|
|
320 keV | 10.08% |
X-ray |
5.2 keV | 22.3% |
|
27.7 days | |
|
18 days total body 1,000 days, bone |
Radiological:
Dose rate:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
40,000 µCi: (by ingestion) 50,000 µCi: (by inhalation) |
|
2 x 10 -5 µCi/mL |
Special Considerations:
In general, Chromium-51 does not require special precautions over and above those necessary for any radionuclide of this energy of emissions. Chromium-51 in the form of chromate is not selectively absorbed by any organ in the body.
Physical Data:
Pure Beta Emitter | |
---|---|
|
18.6 keV (max.) 5.69 keV (avg.) |
|
12.3 years 12 days 12 days 0.6 cm 6 x 10-4 cm |
Radiological:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
8 x 104 µCi: (by ingestion) 8 x 104 µCi: (by inhalation) |
|
2 x 10 -5 µCi/mL |
Special Considerations:
Tritium, because of its low beta energy, cannot be monitored directly, so special care is needed to keep the working environment clean. Regular monitoring by counting swipes is recommended in areas where Tritium is used.
Physical Data: | |
---|---|
|
35 keV 27-32 keV 59.6 days 42 days 120-138 days |
Radiological Data:
Shielding:
Dose Information (assume point source):
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
400 µCi: (by ingestion) 600 µCi: (by inhalation) |
|
3 x 10 -8 µCi/mL |
Special Considerations:
Volatilization of iodine is the most significant problem with this isotope. Simply opening a vial of sodium [I-125] iodide at high radioactive concentration can cause minute droplets of up to 100Bq to become airborne. Solutions containing iodide ions should not be made acidic nor stored frozen: both lead to the formation of volatile elemental iodine. As some iodocompounds can penetrate surgical rubber gloves, it is advisable to wear two pairs or polyethylene gloves over rubber. In the event of suspected or actual significant contamination of personnel, the thyroid should be blocked by administration of stable iodine as, for example, tablets of potassium iodate (170mg) or potassium iodide (130mg). To render any spilled iodine-125 chemically stable, the area of the spill should be treated with alkaline sodium thiosulfate solution before commencing decontamination.
Physical Data: | ||
---|---|---|
Intensity | ||
|
806 keV (max.) 365 keV |
89.3% 81.2% |
|
8 days 80.4 days, thyroid 7.3 days |
Radiological Data:
Shielding:
Survey Instrumentation:
Physical Data:
Pure Beta Emitter | |
---|---|
|
1710.3 keV (max.) 694.9 keV (avg.) |
|
14.26 days 1155 days 14.1 days (bone) 13.5 days (whole body) 611 cm (20 feet) 0.76 cm (0.29 in) 0.61 cm (0.24 in) |
Radiological Data:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
600 µCi: (by ingestion) 900 µCi: (by inhalation) |
|
2 x 10 -5 µCi/mL |
Special Considerations:
P-32 is the highest energy radionuclide commonly encountered in research laboratories and requires special care. Avoid exposure, do not hold tubes containing even small quantities of P-32 any longer than necessary. Use a stand or holder if quantities greater than a few tens of Mbq (=1mCi) are used, and finger dosmeters should be worn. The use of lead-impregnated rubber gloves also is recommended. Even with low-density materials (plastics), the absorption of beta particles gives rise to relatively high-energy Bremstrahlung, which may require some lead shielding when quantities greater than a few hundred Mbq are being handled.
Physical Data: | |
---|---|
|
249 keV (max.) 85 keV (avg.) |
|
25.4 days 19 days 24.9 days |
Radiological Data:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
4000 µCi: (by ingestion) 6000 µCi: (by inhalation) |
|
3 x 10 -6 µCi/mL |
Physical Data: | |
---|---|
|
|
Radiological Data:
Shielding:
Dose Information (assume point source):
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
ALI |
500 µCi: (by ingestion) |
DAC |
3 x 10 -7 µCi/mL |
Special Considerations:
DOSIMETRY AND BIOASSAY REQUIREMENTS:
Physical Data: | ||
---|---|---|
Intensity | ||
|
511 keV 1275 keV 545 keV 2.6 years 10 days (tissue) 500 days (bones) 327.5 days |
180% 100% 90% |
Radiological Data:
Shielding:
Survey Instrumentation:
Physical Data:
Pure Beta Emitter | |
---|---|
|
166.8 keV (max.) 48.63 keV (avg.) |
|
87.51 days 90 days 44.3 days (bone) 13.5 days (whole body) 0.32 mm 10.2 in 0.25 mm |
Radiological Data:
Shielding:
Survey Instrumentation:
Regulatory Compliance: | |
---|---|
|
1 x 104 µCi: (by ingestion) 6 x 10-6 µCi: (by inhalation) |
|
2 x 10 -8 µCi/mL |
Special Considerations:
Note that organic compounds are often strongly retained and no limits of exposure have been set for them. Care also needs to be taken not to generate sulphur dioxide or hydrogen sulphide, which could be inhaled. Radiodysis of S35 amino acids during storage and use may lead to the release of S35 labeled volatile impurities. Although the level of these impurities is small, contamination of the internal surfaces of storage and reaction vessels may occur. Vials should be opened and used in ventilated electrons.
714 W. Lombard St.
Baltimore, MD 21201
The University of Maryland, Baltimore is the founding campus of the University System of Maryland.
620 W. Lexington St., Baltimore, MD
21201 | 410-706-3100